Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future

Clinical Infectious Diseases

Volumn 33, Issue 3, 2001, Pages 381-385

  Shanks, G Dennis ^a   Kain, Kevin C ^b   Keystone, Jay S ^b  

^a ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

8 AMINOQUINOLINE DERIVATIVE; AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMISININ; AZITHROMYCIN; FANSIDAR; HALOFANTRINE; MALOPRIM; PRIMAQUINE; QUININE; TAFENOQUINE;

CHEMOPROPHYLAXIS; COLOMBIA; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENCY; GABON; GASTROINTESTINAL SYMPTOM; GHANA; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HUMAN; INDONESIA; KENYA; MALARIA; MALARIA CONTROL; MULTIDRUG RESISTANCE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELAPSE; REVIEW; SOUTHEAST ASIA;

AMINOQUINOLINES; ANIMALS; ANTIMALARIALS; DRUG RESISTANCE; HUMANS; MALARIA; PLASMODIUM; PRIMAQUINE; TRAVEL;

EID: 0034928103     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/321866     Document Type: Review

References (20)

1. Malaria at Christmas: Risks of prophylaxis versus risks of malaria
2. Malaria among United States troops in Somalia
3. Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens
4. The effect of continuous and intermittent primaquine therapy on the relapse rate of Chesson strain vivax malaria
5. The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama, P-F-6 strain)
6. Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria
7. Randomized pivotal trial of primaquine for prophylaxis against malaria in Javanese adults in Papua, Indonesia
8. Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: Efficacy and toxicity. A randomized, double-blind, placebo-controlled trial
9. Double-blind, randomized, placebo-controlled assessment of chloroquine/primaquine prophylaxis for malaria in nonimmune Colombian soldiers
10. First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial
11. Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand
12. The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605
13. The efficacy of WR238605 against the blood stages of a chloroquine resistant strain of Plasmodium vivax
14. Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial
15. A new primaquine analogue, tafenoquine (WR238605), for prophylaxis against Plasmodium falciparum malaria
16. A randomized, double-blinded, placebo-controlled trial of tafenoquine for prophylaxis against Plasmodium falciparum in Ghana
17. Malaria chemoprophylaxis with tafenoquine: A randomised study
18. Randomized, double-blind, placebo controlled evaluation of monthly WR 238605 (tafenoquine) for prophylaxis of Plasmodium falciparum and P. vivax in Royal Thai Army soldiers
19. Glucose-6-phosphate dehydrogenase deficiency and related disorders of hexose monophosphate shunt and glutathione metabolism
20. Gametocytocidal and sporontocidal activity of antimalarials against Plasmodium berghei ANKA in ICR mice and Anopheles stephensi mosquitoes